Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    IVQ.AX Gross Margin

    As of 2025-05-24, the Gross Margin of Invitrocue Ltd (IVQ.AX) is 47.1%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    IVQ.AX Gross Margin - Historical Value
    DateValue
    2019-06-30 47.1%
    2018-06-30 36.9%
    2017-06-30 50.6%
    2016-06-30 37%
    2015-06-30 -
    2014-06-30 -
    2013-06-30 -
    2012-06-30 -
    2011-06-30 -
    2010-06-30 100%
    IVQ.AX Gross Margin - Peers Comparison
    TickerNameValue
    ACW.AXActinogen Medical Ltd7775.2%
    ATH.AXAlterity Therapeutics Ltd19900%
    ATX.AXAmplia Therapeutics Ltd92.4%
    BIT.AXBiotron Ltd-120.3%
    BNO.AXBionomics Ltd7775.2%
    CDY.AXCellmid Ltd6367.7%
    CUV.AXClinuvel Pharmaceuticals Ltd101.2%
    CYP.AXCynata Therapeutics Ltd85.7%
    DXB.AXDimerix Ltd60%
    EX1.AXExopharm Ltd4.5%
    HXL.AXHexima Ltd89.3%
    IMM.AXImmutep Ltd-933%
    IMU.AXImugene Ltd100%
    KZA.AXKazia Therapeutics Ltd77.6%
    LCT.AXLiving Cell Technologies Ltd44.3%
    MDC.AXMedlab Clinical Ltd100%
    MSB.AXMesoblast Ltd-166.3%
    NSB.AXNeuroScientific Biopharmaceuticals Ltd87.5%
    OPT.AXOpthea Ltd-53.9%
    PAB.AXPatrys Ltd100%
    PAR.AXParadigm Biopharmaceuticals Ltd99.9%
    PYC.AXPYC Therapeutics Ltd-734868%
    RAC.AXRace Oncology Ltd-1165%
    SCU.AXStemcell United Ltd-2.8%
    TDL.AXTBG Diagnostics Ltd58%
    TLX.AXTelix Pharmaceuticals Ltd61.8%
    VBS.AXVectus Biosystems Ltd66%
    Tickers added to watchlist